Contemporary Pharmacotherapy for Allergic Rhinitis and Chronic Rhinosinusitis

Publication date: Available online 28 September 2017
Source:Otolaryngologic Clinics of North America
Author(s): Saied Ghadersohi, Bruce K. Tan

Teaser

Chronic rhinosinusitis (CRS) and allergic rhinitis (AR) are chronic conditions causing nasal inflammation. CRS is increasingly recognized as a chronic inflammatory process rather than a chronic infection. Although the primary initiating factors in CRS remain unclear, AR is driven by IgE-mediated hypersensitivity to environmental allergens. Understanding the underlying inflammatory pathways and disease endotypes are driving innovation toward novel pharmacotherapies targeting critical mediators implicated in CRS and AR, including IL-4, IL-13, IL-5, IgE, and epithelial initiators IL-33 and TSLP. Extensive investigations are needed to determine the role, timing, predictive prognostic factors and long-term safety and efficacy of these agents.


from ORL via alkiviadis.1961 on Inoreader http://ift.tt/2yMJaLP